Current Weather
The Spy FM

Malaria Drug Subsidies: Good Idea Or Wrong Path?

Filed by KOSU News in Health.
October 31, 2012

A month ago we wrote about results from an experiment in getting the most effective malaria drugs to more people who need them in Africa.

The idea was to subsidize the cost of drugs, sometimes to a price point below their wholesale cost, and make them more widely available.

Now the findings, presented publicly at a meeting in Washington, have been published in The Lancet.

In most of the countries where the subsidies were tried, the share of the market for artemisinin-combination therapies, or ACTs, went up a lot. In Zanzibar (part of Tanzania) and Nigeria, the ACT drugs helped drive down sales of one-drug treatments. Those so-called monotherapies, which are cheaper, are a problem because they can spur drug-resistant malaria.

The Affordable Medicines Facility-malaria program, or AMFm, brought more than 100 million doses of malaria drugs to clinics and pharmacies in 2011.

“The programme has been highly controversial,” the authors of the study acknowledge. A big worry: Middlemen would pocket the subsidies and consumers, especially the poorest ones, wouldn’t benefit.

Others say the program, a pilot test of the concept, hasn’t been able to show it saves lives or made a dent in resistance. The aid group Oxfam blasted the approach, saying it’s risky and a distraction:

The Affordable Medicine Facility–malaria has shown no evidence that it has saved the lives of the most vulnerable or delayed drug resistance. Rather, this global subsidy has incentivised medicine sales without diagnosis and shown no evidence that it has served poor people. It poses a risk to public health and could skew investment away from effective solutions.

Oxfam recommends that the board of the Global Fund pull the plug on it next month.

But supporters of the idea, writing an accompanying editorial in The Lancet, disagree, saying a board vote against the program would be a mistake:

Most importantly, it will kill a programme that, when fully implemented, rapidly met its benchmarks despite the many constraints, expectations and unrealistic timelines imposed on it. We must acknowledge that an efficient approach to subsidising antimalarial drugs has worked, making them available in the private sector where people go to buy them.

[Copyright 2012 National Public Radio]

Leave a Reply

9AM to 10AM The Takeaway

The Takeaway

A fresh alternative in morning news, "The Takeaway" provides a breadth and depth of world, national and regional news coverage that is unprecedented in public media.

Listen Live Now!

10AM to 11PM On Point

On Point

On Point unites distinct and provocative voices with passionate discussion as it confronts the stories that are at the center of what is important in the world today. Leaving no perspective unchallenged, On Point digs past the surface and into the core of a subject, exposing each of its real world implications.

View the program guide!

11AM to 12PM The Story

The Story

The Story with Dick Gordon brings the news home through first-person accounts. The live weekday program is passionate, personal, immediate and relevant to listeners, focusing on the news where it changes our lives, causes us to stop and rethink, inspires us.

View the program guide!

Upcoming Events in your area (Submit your event today!)

Streaming audio and podcasts

Stream KOSU on your smartphone

Phone Streaming

SmartPhone listening options on this page are intended for many iPhones, Blackberries, etc. with low-cost software applications available to listen to our full-time web streams, both News on KOSU-1 and Classical on KOSU-2.

Learn more about our complete range of streaming services

We're perfecting the patient experience - Stillwater Medical Center